Egypt Clinical Nutrition Market Analysis

Egypt Clinical Nutrition Market Executive Summary

The Egypt Clinical Nutrition Market is at around $85.9 Mn in 2023 and is projected to reach $136.5 Mn in 2030, exhibiting a CAGR of 6.84% during the forecast period 2023-2030.

Clinical nutrition is the application of nutrition principles to promote health and prevent disease in individuals, particularly in a healthcare setting. It involves assessing patients' nutritional needs, creating personalized nutrition plans, and implementing evidence-based interventions to improve health outcomes. Clinical nutrition centres on the prevention, diagnosis, and management of nutritional changes in patients linked to chronic diseases and conditions primarily in health care. Clinical in this sense refers to the management of patients, including not only outpatients at clinics and in private practice, but also inpatients in hospitals. It incorporates primarily the scientific fields of nutrition and dietetics. Furthermore, clinical nutrition aims to maintain a healthy energy balance, while also providing sufficient amounts of nutrients such as protein, vitamins, and minerals to patients.

Clinical malnutrition refers to a condition that can be treated with clinical intervention by using specialized nutrients that are considered proper medications rather than as supplements. Clinical nutrition products are useful in maintaining the patient's health and enable the improvement of the body's metabolic system by providing adequate supplements, such as minerals, vitamins, and other supplements. The clinical nutrition sector is undergoing a transformation fuelled by progress in medical research and technology. Key trends such as innovative formulations, personalized nutrition solutions, and the use of bioactive ingredients are emerging. Manufacturers are dedicating resources to R&D to produce products that not only fulfil fundamental nutritional requirements but also provide added health advantages. This emphasis on innovation is fostering competition among industry participants, resulting in a constant flow of new products and therapies tailored to various patient demographics.

The prevalence of diabetes among adults in Egypt was 15.6% in 2019. 44.7% of adult women and 25.9% of adult men in Egypt are living with obesity, higher than the regional averages. The major drivers of Clinical Nutrition industry in Egypt are, increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients.

Some of the major players operating in the Egypt Clinical Nutrition market are Bio Pharma, Eva Pharma, Bio Pure, SEDICO, Abbott Nutrition, Mead Johnson & Company, LLC among others.

Market Dynamics

Market Drivers

Growing Population and Aging Demographics: Egypt has a large population of over 100 Mn people, with a significant portion being young and growing. The proportion of the elderly population (aged 60 and above) is expected to increase from 8.1% in 2020 to 10.2% by 2030. This growing and aging population is driving demand for clinical nutrition products.

Rising Prevalence of Chronic Diseases: Egypt is experiencing an increase in the prevalence of non-communicable diseases such as diabetes, cardiovascular diseases, and cancer. The prevalence of diabetes among adults in Egypt was 15.6% in 2019. 44.7% of adult women and 25.9% of adult men in Egypt are living with obesity, higher than the regional averages. The need for specialized clinical nutrition products to manage and treat these chronic conditions is a key driver for market growth.

Government Initiatives and Regulations: The Egyptian government has established regulations and guidelines for the registration and approval of clinical nutrition products. The government has also implemented initiatives to improve the nutritional status of the population, such as the National Nutrition Strategy. These efforts are supporting the development and adoption of clinical nutrition products in the country.

Market Restraints

Economic Factors and Affordability: Poverty and low employment rates, especially among the youth, can limit the purchasing power of the population and reduce the affordability of clinical nutrition products. Around 32.5% of the population in Egypt lives below the national poverty line. This can be a barrier to the market's growth.

Lack of Awareness and Education: There may be a lack of awareness and understanding among the general population regarding the importance of clinical nutrition, especially for managing chronic health conditions. Only 39.5% of infants aged 0 to 5 months are exclusively breastfed in Egypt, indicating a need for improved nutrition education. Addressing this knowledge gap is crucial for market expansion.

Limited Reimbursement Coverage: There is no formal reimbursement structure in Egypt for clinical nutrition products and medical meals. The lack of reimbursement can limit the accessibility and affordability of these products for the population.

Regulatory Landscape and Reimbursement Scenario

The clinical nutrition market in Egypt is regulated by several government agencies and regulatory bodies, with the Ministry of Health and Population (MoHP) serving as the primary authority. The MoHP is responsible for overseeing the registration, marketing authorization, and quality control of clinical nutrition products in the country, setting guidelines and standards for their manufacturing, labeling, and distribution. The Egyptian Drug Authority (EDA), a subsidiary of the MoHP, also plays a key role in regulating and controlling pharmaceutical products, including clinical nutrition supplements and medical foods. Additionally, the National Nutrition Institute (NNI), a research and advisory body under the MoHP, provides technical expertise and guidance on nutrition-related policies and programs, contributing to the development of national guidelines and standards for clinical nutrition practices and products.

In terms of reimbursement, the Egyptian Health Insurance Organization (EHIO), the largest public health insurance provider covering around 60% of the population, offers limited coverage for certain clinical nutrition products, particularly for patients with chronic diseases like diabetes and malnutrition. Private insurance companies, such as Misr Insurance, Suez Canal Insurance, and Egyptians Insurance, may also provide coverage for clinical nutrition products, but the scope and extent of coverage can vary significantly between different plans and providers.

Competitive Landscape

Key Players

Here are some of the major key players in the Egypt Clinical Nutrition Market:

• Bio Pharma
• Mega Pharma
• Bio Pure
• Biostream Pharmaceuticals
• Eva Pharma
• Pharco Pharma
• SEDICO
• Abbott Nutrition
• Nestle
• Otsuka Holdings Co., Ltd.
• Mead Johnson & Company, LLC
• Danone